Nonhypotensive Low-Dose Nesiritide Has Differential Renal Effects Compared With Standard-Dose Nesiritide in Patients With Acute Decompensated Heart Failure and Renal Dysfunction

Journal of the American College of Cardiology

Volumn 47, Issue 11, 2006, Pages 2334-2335

  Riter, Henry G ^a   Redfield, Margaret M ^a   Burnett, John C ^a   Chen, Horng H ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIURETIC AGENT; FUROSEMIDE; NESIRITIDE;

ACUTE HEART FAILURE; BLOOD PRESSURE MEASUREMENT; CLINICAL TRIAL; COMPARATIVE STUDY; DIURETIC THERAPY; DOSE RESPONSE; FOOD AND DRUG ADMINISTRATION; HEART EJECTION FRACTION; HEMODYNAMICS; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY PERFUSION; LETTER; PRIORITY JOURNAL;

ACUTE DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART FAILURE, CONGESTIVE; HUMANS; KIDNEY; KIDNEY DISEASES; NATRIURETIC AGENTS; NATRIURETIC PEPTIDE, BRAIN;

EID: 33646916616     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2006.03.013     Document Type: Letter

References (8)

1. Chen H.H., and Burnett Jr. J.C. The natriuretic peptides in heart failure. diagnostic and therapeutic potentials. (review). Proc Assoc Am Physicians 111 (1999) 406-416
2. Publication Committee for the VMAC Investigators. Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure. a randomized controlled trial. JAMA 287 (2002) 1531-1540
3. Colucci W.S., Elkayam U., Horton D.P., et al., Nesiritide Study Group. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. (erratum appears in N Engl J Med 2000;343:896). N Engl J Med 343 (2000) 246-253
4. Marcus L.E., Hart D., Packer M., et al. Hemodynamic and renal excretory effects of human brain natriuretic peptide infusion in patients with congestive heart failure. Circulation 94 (1996) 3184-3189
5. Wang D.J., Dowling T.C., Meadows D., et al. Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine. Circulation 110 (2004) 1620-1625
6. Sackner-Bernstein J.D., Skopicki H.A., and Aaronson K.D. Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure. Circulation 111 (2005) 1487-1491
7. Chen H.H., Grantham J.A., Schirger J.A., Michihisa J., Redfield M.M., and Burnett Jr. J.C. Subcutaneous administration of brain natriuretic peptide in experimental heart failure. J Am Coll Cardiol 36 (2000) 1706-1712
8. Brunner-La Rocca H.P., Kaye D.M., Woods R.L., Hastings J., and Esler M.D. Effects of intravenous brain natriuretic peptide on regional sympathetic activity in patients with chronic heart failure as compared with healthy control subjects. J Am Coll Cardiol 37 (2001) 1221-1227